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ABSTRACT 
Background: Transient neurological deficits are relatively common after direct 
revascularization surgery for moyamoya disease. Although recent evidence has revealed 
the clinical features and pathophysiology, preoperative predictors have remained unclear. 
This study investigated whether the apparent diffusion coefficient in normal-appearing 
white matter on magnetic resonance imaging could offer a predictor of postoperative 
transient neurological deficits. Methods: This study included adult patients with 
moyamoya disease who underwent superficial temporal artery-middle cerebral artery 
bypass. Preoperative apparent diffusion coefficients were measured in normal-appearing 
white matter on ipsilateral hemisphere. Single photon emission computed tomography 
with 123I-iodoamphetamine was performed on postoperative day 2-6. Relationships 
between mean apparent diffusion coefficient and postoperative transient neurological 
deficits were assessed. Results: Twenty of the 26 subjects (76.9%) experienced 
transient neurological deficits. Focal hyperemia on postoperative single photon 
emission computed tomography appeared in 11 of the 20 subjects with postoperative 
transient neurological deficits and 1 of the 6 subjects without (P=0.12). Mean apparent 
  
diffusion coefficients in patients with and without postoperative transient neurological 
deficits were 748.3±12 mm2/s ×10-6 and 679.7±21.9 mm2/s ×10-6, respectively 
(P=.0091). Conclusions: Preoperative apparent diffusion coefficient elevation in 
normal-appearing white matter may indicate postoperative transient neurological 
deficits not only in patients with postoperative hyperemia on single photon emission 
computed tomography, but also in patients with this pathology. 
  
INTRODUCTION 
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by 
progressive stenosis or occlusion of bilateral internal carotid arteries in association with 
development of basal collateral vascular networks.(1) Direct revascularization surgery, 
such as superficial temporal artery (STA)-middle cerebral artery (MCA) bypass, has 
been established as a beneficial intervention to increase cerebral blood flow (CBF), 
guard against ischemic stroke and provide long-term favorable outcomes for 
ischemic-type MMD.(2) Until recently, whether direct revascularization for patients 
with hemorrhagic onset could prevent rebleeding has been controversial. Results of the 
Japan Adult Moyamoya trial revealed that extracranial-intracranial bypass surgery had 
the potential to prevent rebleeding events in hemorrhagic-type MMD.(3) Direct 
revascularization can thus play a protective role in the management of this disease. 
However, this surgery has some potential perioperative complications. Transient 
neurological deficits have been recognized as a major event developing after 
surgery.(4,5) Postoperative CBF studies have shown a variety of cerebral 
hemodynamics, including focal hyperperfusion,(2) no change/normalization and 
  
hypoperfusion.(6) Such evidence indicates that transient neurological deficits reflect 
varying hemodynamic statuses after this surgery, so this specific condition needs to be 
treated based on an analysis of postoperative CBF. However, the lack of efficient 
preoperative predictors of postoperative symptoms remains problematic. To resolve this 
issue, parameters from preoperative imaging able to predict these postoperative events 
are required. 
The apparent diffusion coefficient (ADC) from diffusion-weighted imaging (DWI) has 
been used as a marker of subtle structural changes in normal-appearing white matter 
(NAWM) on T2-weighted and fluid-attenuated inversion recuperation (FLAIR) 
imaging.(7,8) Elevated ADC in NAWM has been identified in cases of extracranial 
internal carotid artery stenosis(8) and ischemic leukoaraiosis,(7) and in the elderly.(9) 
Recent evidence from a CBF study in patients with MMD has shown that ADC 
elevation in NAWM correlates with severe reductions in cerebrovascular reserve 
(CVR).(10-12) 
Calviere et al.(10) and Nakamizo et al.(13) indicated a correlation between ADC 
elevation in NAWM and long-term neurological impairment in patients with MMD, but 
  
relationships between preoperative ADC and perioperative transient neurological 
deficits have not been clarified. 
Here, we hypothesized that more severely impaired CVR would be associated with 
increased susceptibility to postoperative events. This study therefore investigated 
whether preoperative elevation of ADC in NAWM could provide a predictor of 
postoperative transient neurological deterioration. 
 
MATERIALS AND METHODS 
Patients 
Data were obtained from charts and radiological records for patients treated at Kyoto 
University Hospital between August 2009 and February 2012. Twenty-six Japanese 
patients with angiographically confirmed adult MMD (7 men, 19 women; mean age, 
38.3 years; range, 20-52 years) participated in this study. No patients had coexisting 




Surgery and postoperative management 
Direct revascularization comprised STA-MCA single bypass in all cases. Indirect 
revascularization methods were not included. In our institution, the STA graft is usually 
anastomosed to the superior trunk of the MCA. After the surgery, blood pressure was 
kept in control with preoperative level. The antiplatelets were restarted postoperative 
day two or three after no hemorrhagic complication was confirmed on radiological 
examination. 
 
Measurement of preoperative mean ADC in NAWM 
MRI was conducted using a 3-T scanner (Magnetom Trio; Siemens, Erlangen, 
Germany) with a 32-channel phased-array head coil. DWI was obtained using a 
single-shot echo-planar sequence with the following sequence protocol: repetition time, 
4200 ms; echo time, 78 ms; field of view, 220 × 220 mm; matrix, 128 × 128; slice 
thickness, 3 mm; slice gap, 0.99 mm; number of excitations, 3; b=0, 1000 mm2/s with 3 
principal axes. The resulting DWI and ADC data were transferred to a separate 
workstation for analysis. ADC data were normalized into Montreal Neurological 
  
Institute space with the corresponding b0 images and segmented by cortex and white 
matter using SPM8 software (www.fil.ion.ucl.ac.uk/spm/). Two or three regions of 
interest (ROIs) were placed on the ADC map in NAWM at the level of centrum 
semiovale or corona radiata, where a FLAIR axial slice about 50 mm above the 
orbitomeatal baseline showed no abnormality on the operated side (Fig. 1). The shape of 
each ROI was a circle with a diameter of 1 cm. When setting ROIs, areas containing 
infarction, hemorrhage or apparent artifacts were not selected. 
 
Postoperative evaluation 
Definitions of postoperative transient neurological deficits were: 1) neurological signs, 
including neurological deficits and/or severe headache; 2) natural relief of deficits in the 
short term; 3) absence of new stroke or surgery-related complications as confirmed by 
postoperative MRI. MRI, including MR angiography (MRA), DWI, FLAIR and 
T2*-weighted imaging, and resting-state 123I-iodoamphetamine (IMP)-single photon 
emission computed tomography (SPECT) were performed on postoperative day 2-6 for 
all participants. SPECT was acquired at resting state using a 2-head rotating gamma 
  
camera (Infinia; GE Medical Systems, Milwaukee, USA) with an extended low-energy 
general-purpose collimator. Patients were asked to keep the eyes closed during scanning. 
A bolus of N-isopropyl-p-123I-IMP (167 MBq) was administered at the beginning of 
image acquisition. Data were acquired in a 64 × 64 matrix through a 120° rotation at 
angle intervals of 4°. Total imaging time was 30 min. Spatial resolution at the center of 
view was 9.9 mm in full-width at half-maximum (FWHM) activity. Transverse 
reconstruction with Ramp and Butterworth filters (cutoff of 0.5 cycles/pixel and order 
10), and attenuation correction using the method of Chang (0.07/cm) were applied. 
FWHM of the collimator was 10 mm. In evaluating the results of SPECT, marked CBF 
increases in focal vascular territories were defined as focal hyperemia. 
 
Statistical analysis 
Univariate analysis was performed to investigate relationships between mean ADC in 
NAWM for patients with and without postoperative transient neurological deficits. The 
Mann-Whitney U test was used to calculate P-values for non-parametric data. To 
determine whether preoperative ADC in NAWM could predict postoperative transient 
  
neurological deficits, a receiver operating characteristics (ROC) curve was constructed. 
Cut-off values were set using the Youden index. Patients were divided into two groups 
using this cut-off value. Fisher’s exact test examined the relationship between focal 
hyperemia on postoperative SPECT, mean ADC and transient neurological deficits after 
revascularization. Statistical data were generated using JMP version 10.0.2 software 
(SAS Institute, Cary, NC). Values of P<0.05 were considered statistically significant. 
 
RESULTS 
Among the 26 subjects, 20 (76.9%) showed transient neurological deficits after 
revascularization and the remaining 6 patients (23.1%) did not. Symptoms appeared in 
the early postoperative period (mean, 3 days; range, 0-7 days) and resolved in the short 
term. All symptoms appeared contralateral to the side of surgery and are summarized in 
Table 1. Postoperative MRI, including MRA, DWI and T2*-weighted imaging, revealed 
all bypasses were patent and no evidence of perioperative stroke events in any patients. 
Focal hyperemia on postoperative SPECT appeared in 11 of 20 subjects with 
postoperative transient neurological deficits and in 1 of 6 subjects without (P=0.12). 
  
Mean ADCs in patients with and without postoperative transient neurological deficits 
were 748.3±12 mm2/s ×10-6 and 679.7±21.9 mm2/s ×10-6, respectively (P=0.0091). The 
box-and-whisker plot of this result is shown in Figure 2. Using the Youden index from 
the ROC curve (705.5; 70% sensitivity and 83.3% specificity), a significant relationship 
between mean ADC and transient neurological deficits after revascularization was 
identified (P=0.032, Table 2). 
 
DISCUSSION 
In this study, preoperatively elevated diffusion in NAWM offered a predictor of 
postoperative transient neurological deficits in patients with adult MMD. This is the 
first report to present a relationship between preoperative ADC and transient 
neurological deficits after revascularization surgery. 
ADC elevation has been reported to reflect water diffusivity due to axonal loss with 
subtle structural changes in NAWM.(7) Such structural damage has been observed in 
experimental models of chronic hypoperfusion in which white matter shows glial 
activation, axonal damage and rarefaction with demyelination.(14,15) Conklin et al. 
  
offered the first evidence that subtle ischemic changes might be present in regions of 
steal phenomenon in the NAWM of patients with MMD, leading to increased ADC in 
these areas.(11) 
Postoperative transient neurological deterioration is known to be a relatively common 
event after revascularization surgery. CBF studies have demonstrated that these 
symptoms result from hemodynamic conversion resulting from surgery. Postoperative 
hyperperfusion was recognized as the main contributor after STA-MCA bypass and 
carotid endarterectomy (CEA) for atherosclerotic condition.(16,17) In MMD, 
postoperative hyperperfusion has recently come to be considered as a cause of transient 
neurological deterioration.(2) However, Hayashi et al. reported from the results of CBF 
analysis in pediatric moyamoya cases that perioperative neurological deterioration 
might be attributable to focal ischemia after successful bypass surgery, called 
“watershed shift”.(18) Furthermore, in patients with postoperative transient neurological 
deterioration, postoperative CBF studies have shown either no change or normalization 
compared with preoperative (9 of 20 subjects (45%) in this study). Although these 
differences may originate from “static” and “fluctuating” cerebral hemodynamics in 
  
atherosclerotic disease and MMD, respectively, the underlying mechanisms remain 
unclear. This study focused on not only hyperperfusion syndrome, but also relationships 
with transient neurological deterioration and preoperative ADC. As mentioned above, 
understanding predictive information that suggests whether postoperative neurological 
deterioration may occur has clinical significance for proper treatment to avoid 
permanent neurological sequelae.  
On the other hand, postoperative management has a critical role in this disease. 
Management with the basis of prophylactic blood pressure lowering may resolve 
transient neurological deficits from hyperemic state after revasculization surgery.(19)  
But compulsory blood pressure lowering has possibility to induce low cerebral 
perfusion pressure on untreated region especially in patients with advanced stage. 
Considering this concern, we have carried “habitual blood pressure” control in the 
perioperative period.  
Previous investigators have mentioned several preoperative factors to predict 
postoperative transient neurological deterioration. Most such factors correlated with 
hyperperfusion. Ohue et al. noted that ischemic-onset patients could be suffering 
  
symptomatic hyperperfusion.(20) On the other hand, Fujiumura et al. suggested that 
adult-onset and/or hemorrhagic-onset patients carried a higher risk of symptomatic 
hyperperfusion.(21) The clinical results from estimating postoperative condition have 
been inconsistent. Uchino et al. reported that a preoperative increase in cerebral blood 
volume (CBV) as measured on positron emission tomography (PET) might be useful for 
predicting postoperative radiological and symptomatic hyperperfusion.(22) They 
suggested that increased CBV could indicate autoregulatory vasodilatation in response 
to cerebral perfusion pressure reduction and predict an increased oxygen ejection 
fraction (OEF) in patients with adult MMD, on the basis of previous studies in patients 
with carotid occlusive disease.(23-25) Several parameters have been suggested to 
predict postoperative hyperperfusion, which includes as yet unexplained postoperative 
transient neurological deterioration associated with normalized or unchanged CBF on 
postoperative SPECT compared to preoperatively. 
In the present study, postoperative transient neurological deterioration was accurately 
predicted using Youden index. More importantly, this model could identify symptoms 
that were not associated with hyperemia on postoperative SPECT. What these 
  
symptoms are influenced by is not fully understood, but our data support the hypothesis 
that preoperatively elevated mean ADC in NAWM could offer a predictor of transient 
neurological deterioration developing from slight hemodynamic changes that are 
undetectable on postoperative CBF studies. Furthermore, this is the first report to 
predict postoperative transient neurological deterioration using preoperative MRI data. 
Such results are clinically relevant because MRI is available in many facilities, 
improving applicability in cases where PET or other modality might be unavailable. 
Several limitations must be considered when interpreting the results of this study. First, 
the number of patients was relatively small. The incidence of postoperative neurological 
deterioration was higher than that in previous reports,(2) and the criteria for patient 
selection were not objective, so biases might have influenced the results. Ideally, a 
multicenter, randomized, prospective study should be performed. Second, in this study, 
data from cases with revascularization surgery on one side were combined with data 
from those with revascularization surgery on both sides in the analysis; analyzing these 
data separately would allow a more precise assessment. Improved CBF or CVR 
following contralateral surgery may impact the mean ADC on the ipsilateral side. This 
  
may be a critical issue; to evaluate postoperative hemodynamic change that is 
undetectable using SPECT by ADC comparing with preoperative one and development 
of transient neurological deficits is essential in the further investigation. Also, it is 
certainly important implication for clinicians to predict not transient but permanent 
complication of the surgery. We think final object of our study is to predict permanent 
complication during perioperative period using preoperative information. 
 
CONCLUSIONS 
This is the first study to predict transient postoperative neurological deterioration using 
preoperative mean ADC in adult patients with MMD. Elevated ADC may suggest a risk 
of postoperative symptoms was not correlated with hyperemia on SPECT. To acquire 
more solid evidence and elucidate the detailed mechanisms underlying postoperative 
events, further investigation is essential. 
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Figure 1. Regions of interest (ROIs) were placed in normal-appearing white matter 
(centrum semiovale or corona radiata) on the operated side. A) Fluid-attenuated 
inversion recuperation (FLAIR) axial imaging shows no abnormalities. B) ROIs 
indicated by circles are placed in normal-appearing white matter on the same slice from 
FLAIR imaging. 
 
Figure 2. Preoperative mean apparent diffusion coefficient (ADC) on normal-appearing 
white matter (NAWM) between patients with and without postoperative transient 
neurological deficits. Box-and-whisker plots indicate median value (line in box) and the 
25th (lower line of box) and 75th (upper line of box) percentiles. T bars indicate the 
10th and 90th percentiles. P-values for comparisons between groups were calculated 
using the Mann-Whitney U test. Mean ADCs in patients with and without postoperative 





















44 F L + 5 hand numbness + 
41 F L + 2 COS + 
32 M R + 7 hand numbness - 
51 F L + 1 hand numbness + 
31 M R + 1 
motor weakness in upper extremity, clumsy 
hand 
+ 
29 F L + 1 motor weakness in upper extremity - 
40 F L + 0 partial seizure in upper extremity - 
42 F R + 5 motor weakness in upper extremity - 
52 M R + 2 numbness around mouth, dysarthria + 
38 F L + 7 motor aphasia + 
34 F R + 3 COS + 
30 F L + 1 COS - 
43 F L + 2 COS - 
41 F L + 0 dysarthria, scintillating scotoma - 
22 F R + 7 hand numbness - 
49 M R + 7 hand numbness and clumsiness + 
20 F R + 1 hemiparesis + 
41 F L + 1 COS - 
44 F R + 1 numbness around mouth, dysarthria + 
  
43 F R + 5 COS + 
52 M L -  - - 
44 F L -  - - 
42 M R -  - - 
38 M R -  - + 
28 F R -  - - 
24 F L -  - - 
Op., operated; postop., postoperative; M, male; F, female; L, left; R, right; COS, cheiro-oral syndrome 




Table 2. Transient neurological deficits after 







 Yes No Total 
Mean ADC    
<705.5 6 5 11 
≥705.5* 14 1 15 
Total 20 6 26 
NAWM, normal-appearing white matter; 
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